Downregulation of VPS13C promotes cisplatin resistance in cervical cancer by upregulating GSTP1
Cisplatin resistance remains a major obstacle limiting the effectiveness of chemotherapy in cervical cancer. However, the underlying mechanism of cisplatin resistance is still unclear. Overall design: Cervical cancer control cells and VPS13C-deficient cells were treated with cisplatin for RNA sequencing analysis